BioSpace News Archive

Forma Therapeutics Holdings, Inc. today announced the appointment of John E. Bishop, Ph.D., to the leadership team as senior vice president and chief technology officer.

Sierra Oncology, Inc. today announced it will host an an analyst and investor event on Monday, June 21 at 4:30 pm ET.

Asher Biotherapeutics today announced the formation of its Scientific Advisory Board, with the appointment of five leading scientists in the fields of immunology, oncology and protein therapeutics.

AIM ImmunoTech Inc. today announced that its drug Ampligen has been featured in a publication containing state-of-the-art methodologies in the peer-reviewed medical journal

Mindset Pharma Inc., a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, and InterVivo Solutions, announced the availability of their first data set as part of the Cooperative Psychedelics Evaluation Platform program.

Humana Inc. today announced that it has signed a definitive agreement to acquire One Homecare Solutions (“onehome”) from WayPoint Capital Partners (WayPoint).

Harrow Health, Inc., an ophthalmic-focused healthcare company, announced that it has commenced an underwritten registered public offering of $17.5 million aggregate principal amount of its 8.625% senior notes due 2026, subject to market and certain other conditions.

Sonnet BioTherapeutics Holdings, Inc., announced today that it has changed the date of its upcoming annual meeting of stockholders from June 24, 2021 to Thursday July 15, 2021 at 9:00 a.m., Eastern Time.

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patient’s body, announced that it will take part in a fireside chat at the JMP Securities Life Sciences Conference being held June 16-17, 2021.

Clinical Genomics, a provider of cancer diagnostic solutions, including liquid biopsy tests for minimal residual disease and recurrence monitoring of colorectal cancer, announced that three abstracts were presented at the American Society of Clinical Oncology Annual Meeting, which took place virtually from June 4-8, 2021.